2Nanashima A, Yamagnchi H, Sawai T, et al. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection. J Castroenterol Hepatol, 1999, 14: 1004-1009.
3Ishida T. Immunohistochemical expression of CD44 variant 6 in colorectal adenocarcinoma. Surg Today, 2000, 30: 28-32.
4Tannapfel A, Kockerling F, Katalinic A, et al. Expression of nm23H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum, 1995, 38 : 651-654.
5Forte A, D "Urso A, Gallinaro LS, et al. NM23 expression as prognostic factor in colorectal carcinoma. G Chir, 2002, 23: 61-63.
6Beahrs OH. Staging of cancer of the colon and rectum. Cancer,1992, 70: 1393-1396.
7Hayes DF, Thor AD. c-erbB-2 in breast cancer: development of a clinically useful marker. Semin Oncol, 2002, 29: 231-245.
8Yang JL, Ow KT, Russell PJ, et al. Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors. Ann Surg Oncol,1996, 3: 574-579.
9Nakae S, Shimada E, Urakawa T. Study of c-erbB-2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma. J Surg Oncol, 1993, 54: 246-251.
10Morrin M, Delaney PV. CD44v6 is not relevant in colorectal tumour progression. Int J Colorectal Dis, 2002, 17 : 30-36.
